Home » Project leaders

Project leaders

stefan_endres

Prof. Dr. Stefan Endres

Coordinator of IMMUTRAIN | Director of the Division of Clinical Pharmacology | Ludwig-Maximilians-Universität München | Supervisor of ESR1 and ESR2 within the workpackage 1: Combination of antibodies with adoptive T cell transfer

+49 (0)89 440057300

kobold

PD Dr. Sebastian Kobold

Scientific Coordinator of IMMUTRAIN | Group Leader of Immunopharmacology | Division of Clinical Pharmacology | Ludwig-Maximilians-Universität München | Supervisor of ESR1 and ESR2 within the workpackage 1: Combination of antibodies with adoptive T cell transfer

+49 (0)89 440057325

Bob

Prof. Robert Rees

Director of the Van Geest Cancer Research Centre | Nottingham Trent University | Supervisor of ESR 3 within the work package 1: Combination of antibodies with adoptive T cell transfer

+44 (0) 1158486342

Tarik Regad

Tarik Regad DVetM, MSc, MRes, PhD, FHEA

Senior Research Fellow; 
The John van Geest Cancer Research Centre; Co supervisor of ESR 3; WP 1

+44(0)1158483501

2060114_Max_Schnurr_KUM

Prof. Dr. Max Schnurr

Group Leader Cancer Vaccine Lab | Division of Clinical Pharmacology | Ludwig-Maximilians-Universität München | Supervisor of ESR13 within the work package 4: Target discovery and validation for antibody combination therapies

+49 (0)89 440057309

Adema Gosse

Prof. Gosse Adema

Department of Radiation Oncology Radiotherapy & OncoImmunology Laboratory | Radboud Institute for Molecular Life Sciences | Radboud University Medical Centre | Supervisor of ESR9 within the work package 3: Combination of antibodies with dendritic cell therapy

+31 1243540339

hopfner

Prof. Dr. Karl-Peter Hopfner

Group Leader of Structural Molecular Biology Gene Center | Ludwig-Maximilians-Universität München | Supervisor of ESR6 within the work package 2: New formulations and combinations of antibodies to activate immune cells

+49 (0)89 218076953

Carole Bourquin

Prof. Carole Bourquin

Group Leader Pharmacology | Université de Genève| Supervisor of ESR15 within the work package 4: Target discovery and validation for antibody combination therapies

+41 263009411

claudio Sustmann

Dr. Claudio Sustmann

Head of Dpt. for Molecular Design & Engineering Pharmaceutical Research and Early Development (pRED), Roche Innovation Center Munich, Large Molecule Research | Supervisor of ESR7 within the work package 2: New formulations of antibodies to activate immune cells

+49 8856603356

rescigno

Prof. Maria Rescigno

Director of Experimental Oncology Unit on Dendritic cell biology and Immunotherapy | Istituto Europeo di Oncologia | Supervisor of ESR 8 within the work package 2: New formulations and combinations of antibodies to activate immune cells

+390257489925

Marisol headshot small

Dr. Maria S. Soengas

Head of the Melanoma Group | Spanish National Cancer Research Centre | Supervisor of ESR14 and ESR15 within the work package 4: Target discovery and validation for antibody combination therapies | Co-founder of BiOncotech

+34 917328000

stoitzner

Assoc. Prof. Patrizia Stoitzner

Head of the Langerhans Cell Research Lab | Department of Dermatology,Venereology & Allergology | Medical University of Innsbruck | Supervisor of ESR 10 within the work package 3: Combination of antibodies with dendritic cell therapy

+43 (0) 51250423016

Per_picuture

Prof. Per Thor Straten

Director of the Center for Cancer Immunotherapy | University Hospital Herlev, Region Hovedstaden | Supervisor of ESR4 and ESR5 within the work package 1: Combination of antibodies with adoptive T cell transfer

+45 38689339

zitvogel

Prof. Laurence Zitvogel

Group Leader of Tumour immunology and immunotherapy of cancer | Institut Gustave Roussy | Supervisor of ESR11 within the work package 4: Target discovery and validation for antibody combination therapies

+33 (0) 142114211

Prof. Graham Ball

Head of CompanyDX ltd - UK

0044 (0)115 848 8308

Christian Klein

Dr. Christian Klein

Head Oncology Programs & Department Head Cancer - Roche Innovation Center Zurich - CH

00 41 44 755 61 67

Stefan Strobl

Dr. Stefan Strobl

Head of Small Molecules - BioNTech Smalll Molecules - DE

0049 (0) 89 – 81 888 02 - 0